You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC / CE

Does Vaping in Adolescence Lead to Long-Term Cigarette Use?

  • Authors: News Author: Lara Salahi; CME Author: Charles P. Vega, MD
  • CME / ABIM MOC / CE Released: 5/5/2023
  • Valid for credit through: 5/5/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care clinicians, pediatricians, nurses, pharmacists, physician assistants, and other clinicians who care for adolescents and young adults.

The goal of this activity is for learners to be better able to evaluate the relationship between e-cigarette use during adolescence and later established cigarette smoking.

Upon completion of this activity, participants will:

  • Assess the prevalence of e-cigarette use among US adolescents
  • Evaluate the relationship between e-cigarette use during adolescence and later established cigarette smoking
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Lara Salahi

    Freelance writer, Medscape

    Disclosures

    Lara Salahi has no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor of Family Medicine
    University of California, Irvine School of Medicine
    Irvine, California

    Disclosures

    Charles P. Vega, MD, has the following relevant financial relationships:
    Consultant or advisor for: Boehringer Ingelheim; GlaxoSmithKline; Johnson & Johnson Research & Development, L.L.C.

Editor/Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-150-H99-P).

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 5/5/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Does Vaping in Adolescence Lead to Long-Term Cigarette Use?

Authors: News Author: Lara Salahi; CME Author: Charles P. Vega, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/5/2023

Valid for credit through: 5/5/2024

processing....

Clinical Context

The use of electronic cigarettes (e-cigarettes) continues to be a major public health concern among adolescents, and a study by Cooper and colleagues evaluated the epidemiology of e-cigarette use in this age group in 2022. Their study evaluated data from the National Youth Tobacco Survey, and it was published in the October 7, 2022 issue of Morbidity and Mortality Weekly Report.[1]

A total of 14.1% of high school students and 3.3% of middle school students reported current e-cigarette use. This represented a decrease after peak use of e-cigarettes by adolescents in 2019; 27.6% of e-cigarette users reported daily use of e-cigarettes. Disposable e-cigarettes remained the most popular device, and there were a wider variety of e-cigarette brands used than in previous years. More than three-quarters (84.9%) of e-cigarette users bought flavored products.

One of the principal concerns regarding e-cigarette use is the potential transition to traditional cigarettes. The current study by Sun and colleagues examines the prevalence of this transition and chronic cigarette use.

Study Synopsis and Perspective

Rachel Boykan, MD, clinical professor of pediatrics and attending physician at Stony Brook Children's Hospital, in Stony Brook, New York, said that despite the findings, the overall messaging to patients remains the same: Vaping is linked to smoking.

"There is still a risk of initiation smoking among e-cigarette users -- that is the take-home message," Boykan, who was not affiliated with the study, said. "No risk of smoking initiation is acceptable. And of course, as we are learning, there are significant health risks with e-cigarette use alone."

Among the entire group of teens, approximately 4% of the adolescents began smoking cigarettes; only 2.5% continued to smoke in the subsequent 3 years, the researchers found.

"Based on our odds ratio result, e-cigarette users are more likely to report continued cigarette smoking," said Sun. "However, the risk differences were not significant."

The low numbers of teens who continued to smoke also suggests that adolescents are more likely to quit than become long-term smokers.

Nicotine dependence may adversely affect the ability of adolescents to learn, remember, and maintain attention. Early research[2] has suggested that long-term e-cigarette smokers may be at increased risk of developing some of the same conditions as tobacco smokers, such as chronic lung disease.

Brian Jenssen, MD, a pediatrician at Children's Hospital of Philadelphia and assistant professor in the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, said that the analysis is limited in part because it does not include changes in smoking and vaping trends since the pandemic started, "which seems to have increased the risk of smoking and vaping use."

Data from the 2022 National Youth Tobacco survey[3] found that although the rate of middle school and high school students who begin to use e-cigarettes has steadily decreased during the past 2 decades, students who vape report using the devices more frequently.

Subsequent use of cigarettes is also only one measure of risk from vapes.

"The goal isn't just about cigarettes," said Jenssen, who was not affiliated with the new study. "The goal is about helping children live tobacco- and nicotine-free lives, and there seems to be an increasing intensity of use, which is causing its own health risks."

The current study findings do not change how clinicians should counsel their patients, and they should continue to advise teens to abstain from vaping, he added.

Sun said it's common for youths to experiment with multiple tobacco products.

"Clinicians should continue to monitor youth tobacco-use behaviors, but with their concern being focused on youthful patients who sustain smoking instead of just trying cigarettes," she said

Some of the study authors received support from the National Cancer Institute of the National Institutes of Health and the FDA's Center for Tobacco Products.

Study Highlights

  • Research data was derived from the longitudinal Population Assessment of Tobacco and Health study. The first wave of this study was conducted in 2013, and investigators followed each wave with biennial surveys. The current research focused on adolescents between the ages of 12 and 17 years who initiated study participation in wave 3 (2015-2016) and completed subsequent surveys regarding tobacco and health.
  • Researchers queried participants regarding current and ever-use of e-cigarettes and cigarettes, along with other tobacco products. The main outcome of the current study was the established use of cigarettes, as defined by current cigarette smoking with ≥ 100 cigarettes smoked in the participant’s lifetime.
  • The study analysis focused on the relationship between e-cigarette use in 2015-2016 and the use of cigarettes through 2018-2019. Adolescents who used cigarettes in 2015-2016 were excluded from study analysis.
  • Researchers adjusted the study result to account for demographic variables, exposure to tobacco products at home, school performance, and mental health issues.
  • The analysis included 8671 adolescents: 55.4% were between the ages of 12 and 14 years during their initial survey; 51.1% were male; and 51% were White. 43.7% of participants reported an annual household income < $50,000, and 29.1% reported that they lived with family members who used tobacco products.
  • 9.6% of participants reported ever e-cigarette use in 2015-2016, and 1.6% reported current use.
  • Rates of smoking initiation with cigarettes were low overall (4.1%), and just 0.8% met criteria for established use of cigarettes.
  • 7.4% of e-cigarette users went on to meet criteria for established use of cigarettes compared with 0.7% of participants who did not use e-cigarettes.
  • The adjusted odds ratio for continued smoking associated with ever e-cigarette use at baseline was 1.81 (95% CI: 1.03, 1.18).
  • Still, primarily because of the low overall initiation rate for cigarette smoking, the adjusted risk difference (0.88 percentage points) for smoking in comparing e-cigarette users with nonusers was nonsignificant.

Implications for the healthcare team

  • In a national survey of adolescents in 2022, 14.1% of high school students and 3.3% of middle school students reported current e-cigarette use. More than a quarter (27.6%) of e-cigarette users reported daily use of e-cigarettes. Disposable e-cigarettes remained the most popular device, and 84.9% of e-cigarette users bought flavored products.
  • Although the use of e-cigarettes among adolescents may slightly increase the risk for later cigarette use, the current study suggests that they are not a major driver in promoting continued cigarette use in this important age group.
  • The healthcare team should recommend against e-cigarette use among adolescents but understand that most e-cigarette users will not become established cigarette smokers

 

Earn Credit

  • Print